| __timestamp | Galapagos NV | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9079000 | 4326000 |
| Thursday, January 1, 2015 | 20309000 | 226206000 |
| Friday, January 1, 2016 | 16945000 | 94391000 |
| Sunday, January 1, 2017 | 20559000 | 53821000 |
| Monday, January 1, 2018 | 29641000 | 35463000 |
| Tuesday, January 1, 2019 | 88258000 | 46456000 |
| Wednesday, January 1, 2020 | 162170000 | 71318000 |
| Friday, January 1, 2021 | 167218000 | 135256000 |
| Saturday, January 1, 2022 | 239528000 | 102708000 |
| Sunday, January 1, 2023 | 94252000 | 129620000 |
Unlocking the unknown
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. ImmunityBio, Inc. and Galapagos NV, two prominent players, offer a fascinating study in contrasts. From 2014 to 2023, Galapagos NV's SG&A expenses grew by approximately 940%, peaking in 2022. In contrast, ImmunityBio, Inc. saw a more volatile trajectory, with a significant spike in 2015, where expenses surged to nearly 2.3 times their 2014 levels. By 2023, ImmunityBio's SG&A costs were about 37% higher than in 2014, indicating a more controlled growth compared to Galapagos. This data highlights the strategic differences in cost management between the two companies, with Galapagos showing a steady increase and ImmunityBio experiencing fluctuations. Understanding these trends can provide valuable insights for investors and industry analysts alike.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Cost Management Insights: SG&A Expenses for argenx SE and Galapagos NV
Who Optimizes SG&A Costs Better? Incyte Corporation or ImmunityBio, Inc.
Axsome Therapeutics, Inc. vs Galapagos NV: SG&A Expense Trends
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Galapagos NV
SG&A Efficiency Analysis: Comparing Vericel Corporation and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: ImmunityBio, Inc. vs Dynavax Technologies Corporation
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.
Agios Pharmaceuticals, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Amphastar Pharmaceuticals, Inc. and Galapagos NV